atomoxetina sandoz 60 mg
pharmathen international s.a. - grecia - atomoxetinum - caps. - 60mg - psihostimulante si nootrope simpatomimetice cu actiune centrala
atomoxetina sandoz 80 mg
pharmathen international s.a. - grecia - atomoxetinum - caps. - 80mg - psihostimulante si nootrope simpatomimetice cu actiune centrala
strattera 10 mg
lilly s.a. - spania - atomoxetinum - caps. - 10mg - psihostimulante, med. utilizate in adhd si nootrope simpatomimetice cu actiune centrala
strattera 100 mg
lilly s.a. - spania - atomoxetinum - caps. - 100mg - psihostimulante, med. utilizate in adhd si nootrope simpatomimetice cu actiune centrala
strattera 18 mg
lilly s.a. - spania - atomoxetinum - caps. - 18mg - psihostimulante, med. utilizate in adhd si nootrope simpatomimetice cu actiune centrala
strattera 25 mg
lilly s.a. - spania - atomoxetinum - caps. - 25mg - psihostimulante, med. utilizate in adhd si nootrope simpatomimetice cu actiune centrala
strattera 40 mg
lilly s.a. - spania - atomoxetinum - caps. - 40mg - psihostimulante, med. utilizate in adhd si nootrope simpatomimetice cu actiune centrala
strattera 60 mg
lilly s.a. - spania - atomoxetinum - caps. - 60mg - psihostimulante, med. utilizate in adhd si nootrope simpatomimetice cu actiune centrala
strattera 80 mg
lilly s.a. - spania - atomoxetinum - caps. - 80mg - psihostimulante, med. utilizate in adhd si nootrope simpatomimetice cu actiune centrala
ontilyv
bial portela & companhia s.a. - opicapone - boala parkinson - medicamente anti-parkinson - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.